Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
This study has been terminated.
Study NCT00064636 Information provided by Millennium Pharmaceuticals, Inc.
First Received on July 10, 2003. Last Updated on June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Non-Small Cell Lung Cancer
Other Solid Tumors
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
More general conditions related to this trial
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Millennium Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers